Ming‐Feng Hou - Concepedia

Author

Ming‐Feng Hou

Also Known As

Chen-Yang Shen, Cheng-Hong Yang, Chen‐Yang Shen, Chia-Jung Li, Diana M. Eccles, Helen Tsimiklis, Hou M, Hou, Ming-Feng, James McKay, John L. Hopper

628

Publications

21.5K

Citations

H-Index

223

Concepts

All Affiliations

Kaohsiung Medical University Kaohsiung Medical University Chung-Ho Memorial Hospital National Sun Yat-sen University China Medical University Kaohsiung Municipal Hsiao-Kang Hospital

About

Ming‐Feng Hou is an author at Kaohsiung Medical University specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	131	9.6K
2	Health Sciences	14	15	1.5K
3	Engineering	10	10	661
4	Natural Sciences	10	10	326
5	Business	1	1	50

Ming‐Feng Hou

266

Publications

15.3K

Citations

H-Index

Page 1

	Year	Citations
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies, Hongchao Pan, Jon Godwin, The Lancet Breast OncologyLong-term EffectsMedicineRandomised TrialGynecology	2012	2K
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng, Journal of Clinical Oncology	2020	588
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway Jer-Wei Chang, Wen‐Hung Kuo, Chiao-Mei Lin, Oncogene Breast OncologyGas7 Gene ExpressionCancer BiologyMammary Gland DevelopmentTumor Biology	2018	536
Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers Shou‐Tung Chen, Kong‐Bung Choo, Ming‐Feng Hou, Carcinogenesis	2005	417
Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties Jin‐Ching Lee, Ming‐Feng Hou, Hurng-Wern Huang, Cancer Cell International Marine BiotechnologyEngineeringBiochemistryMedicineAnti-inflammatory Drugs	2013	324
Serum adiponectin and leptin levels in Taiwanese breast cancer patients Da-Chung Chen, Yueh-Fang Chung, Yao-Tsug Yeh, Cancer Letters ObesityMetabolic SyndromeBreast OncologyBody CompositionPathology	2005	318
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study Shubham Pant, Martin Schüler, Gopa Iyer, The Lancet Oncology Fgfr AlterationsMedicinePathologyAdvanced Solid TumoursFibroblast Growth Factor	2023	175
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis Shih‐Hsuan Chan, Wen‐Chin Huang, J-W Chang, Oncogene Breast Cancer MetastasisIntegrin SignalingBreast OncologyFocal Adhesion KinaseMedicine	2014	170
Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer Chih‐Ching Yeh, Ming‐Feng Hou, Shih‐Meng Tsai, Clinica Chimica Acta Breast OncologyOncologyLipid PeroxidesBiochemistryMedicine	2005	161

Page 1